Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Rasouli B, Chubak J, Floyd JS, Psaty BM, Nguyen M, Walker RL, Wiggins KL, Logan RW, Danaei G Combining high quality data with rigorous methods: emulation of a target trial using electronic health records and a nested case-control design 2023 Dec 28;383:e072346. doi: 10.1136/bmj-2022-072346. Epub 2023-12-28. PubMed
Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S Timing of Colposcopy and Risk of Cervical Cancer 2023 Nov;142(5):1125-1134. doi: 10.1097/AOG.0000000000005313. Epub 2023-08-22. PubMed
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds 2023 Oct 2;32(10):1382-1390. doi: 10.1158/1055-9965.EPI-23-0265. Epub 2023-07-14. PubMed
McCarthy AM, Tiro JA, Hu E, Ehsan S, Chubak J, Kamineni A, Feldman S, Atlas SJ, Silver MI, Kobrin S, Haas JS Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems 2023 Oct;35:102279. doi: 10.1016/j.pmedr.2023.102279. Epub 2023-06-11. PubMed
Corley DA, Jensen CD, Chubak J, Schottinger JE, Halm EA, Udaltsova N, Prospr Precise Consortium Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard? 2023 Sep;165(3):784-787.e4. doi: 10.1053/j.gastro.2023.05.025. Epub 2023-05-30. PubMed
Nichols HB, Wernli KJ, Chawla N, O'Meara ES, Gray MF, Green LE, Baggett CD, Casperson M, Chao C, Jones SMW, Kirchhoff AC, Kuo TM, Lee C, Malogolowkin M, Quesenberry CP, Ruddy KJ, Wun T, Zebrack B, Chubak J, Hahn EE, Keegan THM, Kushi LH Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults 2023 Sep;10(3):115-124. doi: 10.1007/s40471-022-00286-9. Epub 2022-03-29. PubMed
Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review 2023 Apr 11;115(4):375-384. doi: 10.1093/jnci/djad028. Epub 2023-02-08. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.